ALGIERS- Algeria will continue the use of the therapeutic protocol based on hydroxychloroquine against the new coronavirus (COVID19), which has contributed "effectively" to the recovery of people suffering from this virus in Algeria, without any side effects, said Wednesday in Algiers Bekkat Berkani, member of the Scientific Committee in charge of monitoring the evolution of the Covid-19 pandemic.
ALGIERS- Minister of Health, Population and Hospital Reform, Abderrahmane Benbouzid said Wednesday that the indicators of the Chloroquine-based therapeutic protocol use to treat COVID-19 "are encouraging and very satisfactory," since the number of the deaths is "decreasing."
ALGIERS- The treatment protocol including chloroquine administered to patients with Covid-19 has proved "almost 100%" effective, specialists told APS.
ALGIERS - Minister Delegate in charge of the pharmaceutical industry Lotfi Benbahmad said Saturday, in Algiers, that new measures will be taken to provide the chloroquine to patients suffering from certain auto-immune diseases.
ALGIERS- Public pharmaceutical group SAIDAL is negotiating with several suppliers on the purchase of raw material for the manufacture of chloroquine, a drug that has proved its effectiveness against the coronavirus, the CEO of Saidal, Fatouma Akacem, said Saturday in Algiers.
ALGIERS- The patients with coronavirus and under chloroquine-based protocol haven’t had any complications, said Professor Reda Mahiaoui, a member of the scientific committee for monitoring the progress of the coronavirus pandemic.
ALGIERS- Minister of Health, Population and Hospital Reform Abderrahmane Benbouzid announced Sunday, in Algiers, the availability of 300,000 boxes of chloroquine and 500,000 boxes of the antibiotic azithromycin to treat patients with Covid-19.
ALGIERS- The minister of Health, Population and Hospital reform, Prof. Abderrahmane Bebouzid, said Thursday in Algiers that the first results of the cases submitted to the chloroquine protocol are "satisfactory."
ALGIERS- The industrial public group "SAIDAL" plans to manufacture and develop the therapeutic protocol, chloroquine, used to treat patients suffering from the coronavirus pandemic (Covid-19), the group marketing and sales director, Youcef Ouakli, told APS on Monday.